Cytosorbents Free Cash Flow 2010-2025 | CTSO
Cytosorbents free cash flow from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Cytosorbents Annual Free Cash Flow | |
|---|---|
| 2024 | -14.71 |
| 2023 | -22.19 |
| 2022 | -34.32 |
| 2021 | -17.65 |
| 2020 | -6.32 |
| 2019 | -17.46 |
| 2018 | -11.51 |
| 2017 | -7.45 |
| 2016 | -6.87 |
| 2015 | -9.45 |
| 2014 | -6.43 |
| 2013 | -3.53 |
| 2012 | -3.64 |
| 2011 | -3.86 |
| 2010 | -2.60 |
| 2009 | -2.68 |
| Cytosorbents Quarterly Free Cash Flow | |
|---|---|
| 2025-06-30 | -5.01 |
| 2025-03-31 | -3.47 |
| 2024-12-31 | -14.71 |
| 2024-09-30 | -12.30 |
| 2024-06-30 | -9.69 |
| 2024-03-31 | -4.88 |
| 2023-12-31 | -22.19 |
| 2023-09-30 | -15.69 |
| 2023-06-30 | -10.34 |
| 2023-03-31 | -3.62 |
| 2022-12-31 | -34.32 |
| 2022-09-30 | -28.77 |
| 2022-06-30 | -21.39 |
| 2022-03-31 | -8.83 |
| 2021-12-31 | -17.65 |
| 2021-09-30 | -10.62 |
| 2021-06-30 | -5.60 |
| 2021-03-31 | -2.77 |
| 2020-12-31 | -6.32 |
| 2020-09-30 | -5.10 |
| 2020-06-30 | -1.59 |
| 2020-03-31 | -3.45 |
| 2019-12-31 | -17.46 |
| 2019-09-30 | -13.19 |
| 2019-06-30 | -7.86 |
| 2019-03-31 | -4.53 |
| 2018-12-31 | -11.51 |
| 2018-09-30 | -8.63 |
| 2018-06-30 | -5.97 |
| 2018-03-31 | -2.45 |
| 2017-12-31 | -7.45 |
| 2017-09-30 | -6.63 |
| 2017-06-30 | -4.10 |
| 2017-03-31 | -2.06 |
| 2016-12-31 | -6.87 |
| 2016-09-30 | -5.81 |
| 2016-06-30 | -3.28 |
| 2016-03-31 | -1.30 |
| 2015-12-31 | -9.45 |
| 2015-09-30 | -7.12 |
| 2015-06-30 | -4.75 |
| 2015-03-31 | -2.07 |
| 2014-12-31 | -6.43 |
| 2014-09-30 | -4.28 |
| 2014-06-30 | -2.32 |
| 2014-03-31 | -0.82 |
| 2013-12-31 | -3.53 |
| 2013-09-30 | -2.42 |
| 2013-06-30 | -1.86 |
| 2013-03-31 | -0.81 |
| 2012-12-31 | -3.64 |
| 2012-09-30 | -2.86 |
| 2012-06-30 | -2.22 |
| 2012-03-31 | -1.07 |
| 2011-12-31 | -3.85 |
| 2011-09-30 | -2.75 |
| 2011-06-30 | -1.64 |
| 2011-03-31 | -0.59 |
| 2010-12-31 | -2.60 |
| 2010-09-30 | -1.80 |
| 2010-06-30 | -1.17 |
| 2010-03-31 | -0.42 |
| 2009-12-31 | -2.68 |
| 2009-09-30 | -2.22 |
| 2009-06-30 | -1.52 |
| 2009-03-31 | -0.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.058B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
| Boston Scientific (BSX) | United States | $157.644B | 37.59 |
| Stryker (SYK) | United States | $150.755B | 30.69 |
| EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
| Medtronic (MDT) | Ireland | $118.256B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
| ResMed (RMD) | United States | $41.753B | 29.86 |
| GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
| Agilent Technologies (A) | United States | $33.605B | 21.91 |
| Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
| Terumo (TRUMY) | Japan | $26.532B | 31.44 |
| Insulet (PODD) | United States | $23.358B | 78.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.337B | 0.00 |
| Baxter (BAX) | United States | $12.584B | 9.72 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
| Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
| Envista Holdings (NVST) | United States | $3.513B | 24.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
| ICU Medical (ICUI) | United States | $3.109B | 21.17 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| Acuren (TIC) | United States | $2.156B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.223B | 19.41 |
| Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.941B | 8.70 |
| Valneva SE (VALN) | France | $0.762B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.683B | 0.00 |
| SNDL (SNDL) | Canada | $0.649B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Surmodics (SRDX) | United States | $0.496B | 0.00 |
| Evolus (EOLS) | United States | $0.495B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
| CeriBell (CBLL) | United States | $0.420B | 0.00 |
| Owens & Minor (OMI) | United States | $0.387B | 3.43 |
| Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.301B | 61.15 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
| Omeros (OMER) | United States | $0.298B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Quanterix (QTRX) | United States | $0.218B | 0.00 |
| Exagen (XGN) | United States | $0.218B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
| Biote (BTMD) | United States | $0.164B | 5.43 |
| Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.32 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 32.90 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.67 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.62 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |